ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Acne Vulgaris Management Market Research Report 2024
Published Date: August 2024
|
Report Code: QYRE-Auto-13D13455
Home | Market Reports | Beauty & Fitness| Face & Body Care| Skin & Nail Care
Global Acne Vulgaris Management Market Research Report 2023
BUY CHAPTERS

Global Acne Vulgaris Management Market Research Report 2024

Code: QYRE-Auto-13D13455
Report
August 2024
Pages:97
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Common Pharma Inc
Cutanea Life Sciences Inc
Dermira
Elorac
Ensol Biosciences Inc
Foamix Pharmaceuticals Ltd
Galderma SA
GlaxoSmithKline PLC
Helix BioMedix Inc
Hovione FarmaCiencia SA
Lee's Pharmaceutical Holdings Ltd
LEO Pharma A/S
NovaBiotics Ltd
Novan
Novartis
Paratek Pharmaceuticals Inc.
Pfizer Inc
Phosphagenics Limited

Acne Vulgaris Management Market

The global Acne Vulgaris Management market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Acne Vulgaris Management is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Acne Vulgaris Management is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Acne Vulgaris Management in Clinic is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Acne Vulgaris Management include Common Pharma Inc, Cutanea Life Sciences Inc, Dermira Inc, ELORAC Inc, Ensol Biosciences Inc, Foamix Pharmaceuticals Ltd, Galderma SA, GlaxoSmithKline Plc and Helix BioMedix Inc, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Acne Vulgaris Management, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Acne Vulgaris Management.

Report Scope

The Acne Vulgaris Management market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Acne Vulgaris Management market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Acne Vulgaris Management companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Acne Vulgaris Management Market Report

Report Metric Details
Report Name Acne Vulgaris Management Market
Segment by Type
  • CB-0601
  • CJM-112
  • CLS-007
  • Dapsone
  • DFD-10
  • DLX-2323
  • Others
Segment by Application
  • Clinic
  • Hospital
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Common Pharma Inc, Cutanea Life Sciences Inc, Dermira Inc, ELORAC Inc, Ensol Biosciences Inc, Foamix Pharmaceuticals Ltd, Galderma SA, GlaxoSmithKline Plc, Helix BioMedix Inc, Hovione FarmaCiencia SA, Lee's Pharmaceutical Holdings Ltd, LEO Pharma A/S, Novabiotics Ltd, Novan Inc, Novartis AG, Paratek Pharmaceuticals Inc, Pfizer Inc, Phosphagenics Ltd
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Acne Vulgaris Management companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Acne Vulgaris Management Market report?

Ans: The main players in the Acne Vulgaris Management Market are Common Pharma Inc, Cutanea Life Sciences Inc, Dermira Inc, ELORAC Inc, Ensol Biosciences Inc, Foamix Pharmaceuticals Ltd, Galderma SA, GlaxoSmithKline Plc, Helix BioMedix Inc, Hovione FarmaCiencia SA, Lee's Pharmaceutical Holdings Ltd, LEO Pharma A/S, Novabiotics Ltd, Novan Inc, Novartis AG, Paratek Pharmaceuticals Inc, Pfizer Inc, Phosphagenics Ltd

What are the Application segmentation covered in the Acne Vulgaris Management Market report?

Ans: The Applications covered in the Acne Vulgaris Management Market report are Clinic, Hospital, Others

What are the Type segmentation covered in the Acne Vulgaris Management Market report?

Ans: The Types covered in the Acne Vulgaris Management Market report are CB-0601, CJM-112, CLS-007, Dapsone, DFD-10, DLX-2323, Others

Recommended Reports

Acne Related Markets

Dermatology Therapeutics

Skin Care & Disorders

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Acne Vulgaris Management Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 CB-0601
1.2.3 CJM-112
1.2.4 CLS-007
1.2.5 Dapsone
1.2.6 DFD-10
1.2.7 DLX-2323
1.2.8 Others
1.3 Market by Application
1.3.1 Global Acne Vulgaris Management Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Acne Vulgaris Management Market Perspective (2019-2030)
2.2 Acne Vulgaris Management Growth Trends by Region
2.2.1 Global Acne Vulgaris Management Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Acne Vulgaris Management Historic Market Size by Region (2019-2024)
2.2.3 Acne Vulgaris Management Forecasted Market Size by Region (2025-2030)
2.3 Acne Vulgaris Management Market Dynamics
2.3.1 Acne Vulgaris Management Industry Trends
2.3.2 Acne Vulgaris Management Market Drivers
2.3.3 Acne Vulgaris Management Market Challenges
2.3.4 Acne Vulgaris Management Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Acne Vulgaris Management Players by Revenue
3.1.1 Global Top Acne Vulgaris Management Players by Revenue (2019-2024)
3.1.2 Global Acne Vulgaris Management Revenue Market Share by Players (2019-2024)
3.2 Global Acne Vulgaris Management Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Acne Vulgaris Management Revenue
3.4 Global Acne Vulgaris Management Market Concentration Ratio
3.4.1 Global Acne Vulgaris Management Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Acne Vulgaris Management Revenue in 2023
3.5 Acne Vulgaris Management Key Players Head office and Area Served
3.6 Key Players Acne Vulgaris Management Product Solution and Service
3.7 Date of Enter into Acne Vulgaris Management Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Acne Vulgaris Management Breakdown Data by Type
4.1 Global Acne Vulgaris Management Historic Market Size by Type (2019-2024)
4.2 Global Acne Vulgaris Management Forecasted Market Size by Type (2025-2030)
5 Acne Vulgaris Management Breakdown Data by Application
5.1 Global Acne Vulgaris Management Historic Market Size by Application (2019-2024)
5.2 Global Acne Vulgaris Management Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Acne Vulgaris Management Market Size (2019-2030)
6.2 North America Acne Vulgaris Management Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Acne Vulgaris Management Market Size by Country (2019-2024)
6.4 North America Acne Vulgaris Management Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Acne Vulgaris Management Market Size (2019-2030)
7.2 Europe Acne Vulgaris Management Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Acne Vulgaris Management Market Size by Country (2019-2024)
7.4 Europe Acne Vulgaris Management Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Acne Vulgaris Management Market Size (2019-2030)
8.2 Asia-Pacific Acne Vulgaris Management Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Acne Vulgaris Management Market Size by Region (2019-2024)
8.4 Asia-Pacific Acne Vulgaris Management Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Acne Vulgaris Management Market Size (2019-2030)
9.2 Latin America Acne Vulgaris Management Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Acne Vulgaris Management Market Size by Country (2019-2024)
9.4 Latin America Acne Vulgaris Management Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Acne Vulgaris Management Market Size (2019-2030)
10.2 Middle East & Africa Acne Vulgaris Management Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Acne Vulgaris Management Market Size by Country (2019-2024)
10.4 Middle East & Africa Acne Vulgaris Management Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Common Pharma Inc
11.1.1 Common Pharma Inc Company Detail
11.1.2 Common Pharma Inc Business Overview
11.1.3 Common Pharma Inc Acne Vulgaris Management Introduction
11.1.4 Common Pharma Inc Revenue in Acne Vulgaris Management Business (2019-2024)
11.1.5 Common Pharma Inc Recent Development
11.2 Cutanea Life Sciences Inc
11.2.1 Cutanea Life Sciences Inc Company Detail
11.2.2 Cutanea Life Sciences Inc Business Overview
11.2.3 Cutanea Life Sciences Inc Acne Vulgaris Management Introduction
11.2.4 Cutanea Life Sciences Inc Revenue in Acne Vulgaris Management Business (2019-2024)
11.2.5 Cutanea Life Sciences Inc Recent Development
11.3 Dermira Inc
11.3.1 Dermira Inc Company Detail
11.3.2 Dermira Inc Business Overview
11.3.3 Dermira Inc Acne Vulgaris Management Introduction
11.3.4 Dermira Inc Revenue in Acne Vulgaris Management Business (2019-2024)
11.3.5 Dermira Inc Recent Development
11.4 ELORAC Inc
11.4.1 ELORAC Inc Company Detail
11.4.2 ELORAC Inc Business Overview
11.4.3 ELORAC Inc Acne Vulgaris Management Introduction
11.4.4 ELORAC Inc Revenue in Acne Vulgaris Management Business (2019-2024)
11.4.5 ELORAC Inc Recent Development
11.5 Ensol Biosciences Inc
11.5.1 Ensol Biosciences Inc Company Detail
11.5.2 Ensol Biosciences Inc Business Overview
11.5.3 Ensol Biosciences Inc Acne Vulgaris Management Introduction
11.5.4 Ensol Biosciences Inc Revenue in Acne Vulgaris Management Business (2019-2024)
11.5.5 Ensol Biosciences Inc Recent Development
11.6 Foamix Pharmaceuticals Ltd
11.6.1 Foamix Pharmaceuticals Ltd Company Detail
11.6.2 Foamix Pharmaceuticals Ltd Business Overview
11.6.3 Foamix Pharmaceuticals Ltd Acne Vulgaris Management Introduction
11.6.4 Foamix Pharmaceuticals Ltd Revenue in Acne Vulgaris Management Business (2019-2024)
11.6.5 Foamix Pharmaceuticals Ltd Recent Development
11.7 Galderma SA
11.7.1 Galderma SA Company Detail
11.7.2 Galderma SA Business Overview
11.7.3 Galderma SA Acne Vulgaris Management Introduction
11.7.4 Galderma SA Revenue in Acne Vulgaris Management Business (2019-2024)
11.7.5 Galderma SA Recent Development
11.8 GlaxoSmithKline Plc
11.8.1 GlaxoSmithKline Plc Company Detail
11.8.2 GlaxoSmithKline Plc Business Overview
11.8.3 GlaxoSmithKline Plc Acne Vulgaris Management Introduction
11.8.4 GlaxoSmithKline Plc Revenue in Acne Vulgaris Management Business (2019-2024)
11.8.5 GlaxoSmithKline Plc Recent Development
11.9 Helix BioMedix Inc
11.9.1 Helix BioMedix Inc Company Detail
11.9.2 Helix BioMedix Inc Business Overview
11.9.3 Helix BioMedix Inc Acne Vulgaris Management Introduction
11.9.4 Helix BioMedix Inc Revenue in Acne Vulgaris Management Business (2019-2024)
11.9.5 Helix BioMedix Inc Recent Development
11.10 Hovione FarmaCiencia SA
11.10.1 Hovione FarmaCiencia SA Company Detail
11.10.2 Hovione FarmaCiencia SA Business Overview
11.10.3 Hovione FarmaCiencia SA Acne Vulgaris Management Introduction
11.10.4 Hovione FarmaCiencia SA Revenue in Acne Vulgaris Management Business (2019-2024)
11.10.5 Hovione FarmaCiencia SA Recent Development
11.11 Lee's Pharmaceutical Holdings Ltd
11.11.1 Lee's Pharmaceutical Holdings Ltd Company Detail
11.11.2 Lee's Pharmaceutical Holdings Ltd Business Overview
11.11.3 Lee's Pharmaceutical Holdings Ltd Acne Vulgaris Management Introduction
11.11.4 Lee's Pharmaceutical Holdings Ltd Revenue in Acne Vulgaris Management Business (2019-2024)
11.11.5 Lee's Pharmaceutical Holdings Ltd Recent Development
11.12 LEO Pharma A/S
11.12.1 LEO Pharma A/S Company Detail
11.12.2 LEO Pharma A/S Business Overview
11.12.3 LEO Pharma A/S Acne Vulgaris Management Introduction
11.12.4 LEO Pharma A/S Revenue in Acne Vulgaris Management Business (2019-2024)
11.12.5 LEO Pharma A/S Recent Development
11.13 Novabiotics Ltd
11.13.1 Novabiotics Ltd Company Detail
11.13.2 Novabiotics Ltd Business Overview
11.13.3 Novabiotics Ltd Acne Vulgaris Management Introduction
11.13.4 Novabiotics Ltd Revenue in Acne Vulgaris Management Business (2019-2024)
11.13.5 Novabiotics Ltd Recent Development
11.14 Novan Inc
11.14.1 Novan Inc Company Detail
11.14.2 Novan Inc Business Overview
11.14.3 Novan Inc Acne Vulgaris Management Introduction
11.14.4 Novan Inc Revenue in Acne Vulgaris Management Business (2019-2024)
11.14.5 Novan Inc Recent Development
11.15 Novartis AG
11.15.1 Novartis AG Company Detail
11.15.2 Novartis AG Business Overview
11.15.3 Novartis AG Acne Vulgaris Management Introduction
11.15.4 Novartis AG Revenue in Acne Vulgaris Management Business (2019-2024)
11.15.5 Novartis AG Recent Development
11.16 Paratek Pharmaceuticals Inc
11.16.1 Paratek Pharmaceuticals Inc Company Detail
11.16.2 Paratek Pharmaceuticals Inc Business Overview
11.16.3 Paratek Pharmaceuticals Inc Acne Vulgaris Management Introduction
11.16.4 Paratek Pharmaceuticals Inc Revenue in Acne Vulgaris Management Business (2019-2024)
11.16.5 Paratek Pharmaceuticals Inc Recent Development
11.17 Pfizer Inc
11.17.1 Pfizer Inc Company Detail
11.17.2 Pfizer Inc Business Overview
11.17.3 Pfizer Inc Acne Vulgaris Management Introduction
11.17.4 Pfizer Inc Revenue in Acne Vulgaris Management Business (2019-2024)
11.17.5 Pfizer Inc Recent Development
11.18 Phosphagenics Ltd
11.18.1 Phosphagenics Ltd Company Detail
11.18.2 Phosphagenics Ltd Business Overview
11.18.3 Phosphagenics Ltd Acne Vulgaris Management Introduction
11.18.4 Phosphagenics Ltd Revenue in Acne Vulgaris Management Business (2019-2024)
11.18.5 Phosphagenics Ltd Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
FEATURED COMPANIES
Common Pharma Inc
Cutanea Life Sciences Inc
Dermira
Elorac
Ensol Biosciences Inc
Foamix Pharmaceuticals Ltd
Galderma SA
GlaxoSmithKline PLC
Helix BioMedix Inc
Hovione FarmaCiencia SA
Lee's Pharmaceutical Holdings Ltd
LEO Pharma A/S
NovaBiotics Ltd
Novan
Novartis
Paratek Pharmaceuticals Inc.
Pfizer Inc
Phosphagenics Limited
List of Tables
    Table 1. Global Acne Vulgaris Management Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
    Table 2. Key Players of CB-0601
    Table 3. Key Players of CJM-112
    Table 4. Key Players of CLS-007
    Table 5. Key Players of Dapsone
    Table 6. Key Players of DFD-10
    Table 7. Key Players of DLX-2323
    Table 8. Key Players of Others
    Table 9. Global Acne Vulgaris Management Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
    Table 10. Global Acne Vulgaris Management Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 11. Global Acne Vulgaris Management Market Size by Region (2019-2024) & (US$ Million)
    Table 12. Global Acne Vulgaris Management Market Share by Region (2019-2024)
    Table 13. Global Acne Vulgaris Management Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 14. Global Acne Vulgaris Management Market Share by Region (2025-2030)
    Table 15. Acne Vulgaris Management Market Trends
    Table 16. Acne Vulgaris Management Market Drivers
    Table 17. Acne Vulgaris Management Market Challenges
    Table 18. Acne Vulgaris Management Market Restraints
    Table 19. Global Acne Vulgaris Management Revenue by Players (2019-2024) & (US$ Million)
    Table 20. Global Acne Vulgaris Management Market Share by Players (2019-2024)
    Table 21. Global Top Acne Vulgaris Management Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Acne Vulgaris Management as of 2023)
    Table 22. Ranking of Global Top Acne Vulgaris Management Companies by Revenue (US$ Million) in 2023
    Table 23. Global 5 Largest Players Market Share by Acne Vulgaris Management Revenue (CR5 and HHI) & (2019-2024)
    Table 24. Key Players Headquarters and Area Served
    Table 25. Key Players Acne Vulgaris Management Product Solution and Service
    Table 26. Date of Enter into Acne Vulgaris Management Market
    Table 27. Mergers & Acquisitions, Expansion Plans
    Table 28. Global Acne Vulgaris Management Market Size by Type (2019-2024) & (US$ Million)
    Table 29. Global Acne Vulgaris Management Revenue Market Share by Type (2019-2024)
    Table 30. Global Acne Vulgaris Management Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 31. Global Acne Vulgaris Management Revenue Market Share by Type (2025-2030)
    Table 32. Global Acne Vulgaris Management Market Size by Application (2019-2024) & (US$ Million)
    Table 33. Global Acne Vulgaris Management Revenue Market Share by Application (2019-2024)
    Table 34. Global Acne Vulgaris Management Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 35. Global Acne Vulgaris Management Revenue Market Share by Application (2025-2030)
    Table 36. North America Acne Vulgaris Management Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 37. North America Acne Vulgaris Management Market Size by Country (2019-2024) & (US$ Million)
    Table 38. North America Acne Vulgaris Management Market Size by Country (2025-2030) & (US$ Million)
    Table 39. Europe Acne Vulgaris Management Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 40. Europe Acne Vulgaris Management Market Size by Country (2019-2024) & (US$ Million)
    Table 41. Europe Acne Vulgaris Management Market Size by Country (2025-2030) & (US$ Million)
    Table 42. Asia-Pacific Acne Vulgaris Management Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 43. Asia-Pacific Acne Vulgaris Management Market Size by Region (2019-2024) & (US$ Million)
    Table 44. Asia-Pacific Acne Vulgaris Management Market Size by Region (2025-2030) & (US$ Million)
    Table 45. Latin America Acne Vulgaris Management Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 46. Latin America Acne Vulgaris Management Market Size by Country (2019-2024) & (US$ Million)
    Table 47. Latin America Acne Vulgaris Management Market Size by Country (2025-2030) & (US$ Million)
    Table 48. Middle East & Africa Acne Vulgaris Management Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 49. Middle East & Africa Acne Vulgaris Management Market Size by Country (2019-2024) & (US$ Million)
    Table 50. Middle East & Africa Acne Vulgaris Management Market Size by Country (2025-2030) & (US$ Million)
    Table 51. Common Pharma Inc Company Detail
    Table 52. Common Pharma Inc Business Overview
    Table 53. Common Pharma Inc Acne Vulgaris Management Product
    Table 54. Common Pharma Inc Revenue in Acne Vulgaris Management Business (2019-2024) & (US$ Million)
    Table 55. Common Pharma Inc Recent Development
    Table 56. Cutanea Life Sciences Inc Company Detail
    Table 57. Cutanea Life Sciences Inc Business Overview
    Table 58. Cutanea Life Sciences Inc Acne Vulgaris Management Product
    Table 59. Cutanea Life Sciences Inc Revenue in Acne Vulgaris Management Business (2019-2024) & (US$ Million)
    Table 60. Cutanea Life Sciences Inc Recent Development
    Table 61. Dermira Inc Company Detail
    Table 62. Dermira Inc Business Overview
    Table 63. Dermira Inc Acne Vulgaris Management Product
    Table 64. Dermira Inc Revenue in Acne Vulgaris Management Business (2019-2024) & (US$ Million)
    Table 65. Dermira Inc Recent Development
    Table 66. ELORAC Inc Company Detail
    Table 67. ELORAC Inc Business Overview
    Table 68. ELORAC Inc Acne Vulgaris Management Product
    Table 69. ELORAC Inc Revenue in Acne Vulgaris Management Business (2019-2024) & (US$ Million)
    Table 70. ELORAC Inc Recent Development
    Table 71. Ensol Biosciences Inc Company Detail
    Table 72. Ensol Biosciences Inc Business Overview
    Table 73. Ensol Biosciences Inc Acne Vulgaris Management Product
    Table 74. Ensol Biosciences Inc Revenue in Acne Vulgaris Management Business (2019-2024) & (US$ Million)
    Table 75. Ensol Biosciences Inc Recent Development
    Table 76. Foamix Pharmaceuticals Ltd Company Detail
    Table 77. Foamix Pharmaceuticals Ltd Business Overview
    Table 78. Foamix Pharmaceuticals Ltd Acne Vulgaris Management Product
    Table 79. Foamix Pharmaceuticals Ltd Revenue in Acne Vulgaris Management Business (2019-2024) & (US$ Million)
    Table 80. Foamix Pharmaceuticals Ltd Recent Development
    Table 81. Galderma SA Company Detail
    Table 82. Galderma SA Business Overview
    Table 83. Galderma SA Acne Vulgaris Management Product
    Table 84. Galderma SA Revenue in Acne Vulgaris Management Business (2019-2024) & (US$ Million)
    Table 85. Galderma SA Recent Development
    Table 86. GlaxoSmithKline Plc Company Detail
    Table 87. GlaxoSmithKline Plc Business Overview
    Table 88. GlaxoSmithKline Plc Acne Vulgaris Management Product
    Table 89. GlaxoSmithKline Plc Revenue in Acne Vulgaris Management Business (2019-2024) & (US$ Million)
    Table 90. GlaxoSmithKline Plc Recent Development
    Table 91. Helix BioMedix Inc Company Detail
    Table 92. Helix BioMedix Inc Business Overview
    Table 93. Helix BioMedix Inc Acne Vulgaris Management Product
    Table 94. Helix BioMedix Inc Revenue in Acne Vulgaris Management Business (2019-2024) & (US$ Million)
    Table 95. Helix BioMedix Inc Recent Development
    Table 96. Hovione FarmaCiencia SA Company Detail
    Table 97. Hovione FarmaCiencia SA Business Overview
    Table 98. Hovione FarmaCiencia SA Acne Vulgaris Management Product
    Table 99. Hovione FarmaCiencia SA Revenue in Acne Vulgaris Management Business (2019-2024) & (US$ Million)
    Table 100. Hovione FarmaCiencia SA Recent Development
    Table 101. Lee's Pharmaceutical Holdings Ltd Company Detail
    Table 102. Lee's Pharmaceutical Holdings Ltd Business Overview
    Table 103. Lee's Pharmaceutical Holdings Ltd Acne Vulgaris Management Product
    Table 104. Lee's Pharmaceutical Holdings Ltd Revenue in Acne Vulgaris Management Business (2019-2024) & (US$ Million)
    Table 105. Lee's Pharmaceutical Holdings Ltd Recent Development
    Table 106. LEO Pharma A/S Company Detail
    Table 107. LEO Pharma A/S Business Overview
    Table 108. LEO Pharma A/S Acne Vulgaris Management Product
    Table 109. LEO Pharma A/S Revenue in Acne Vulgaris Management Business (2019-2024) & (US$ Million)
    Table 110. LEO Pharma A/S Recent Development
    Table 111. Novabiotics Ltd Company Detail
    Table 112. Novabiotics Ltd Business Overview
    Table 113. Novabiotics Ltd Acne Vulgaris Management Product
    Table 114. Novabiotics Ltd Revenue in Acne Vulgaris Management Business (2019-2024) & (US$ Million)
    Table 115. Novabiotics Ltd Recent Development
    Table 116. Novan Inc Company Detail
    Table 117. Novan Inc Business Overview
    Table 118. Novan Inc Acne Vulgaris Management Product
    Table 119. Novan Inc Revenue in Acne Vulgaris Management Business (2019-2024) & (US$ Million)
    Table 120. Novan Inc Recent Development
    Table 121. Novartis AG Company Detail
    Table 122. Novartis AG Business Overview
    Table 123. Novartis AG Acne Vulgaris Management Product
    Table 124. Novartis AG Revenue in Acne Vulgaris Management Business (2019-2024) & (US$ Million)
    Table 125. Novartis AG Recent Development
    Table 126. Paratek Pharmaceuticals Inc Company Detail
    Table 127. Paratek Pharmaceuticals Inc Business Overview
    Table 128. Paratek Pharmaceuticals Inc Acne Vulgaris Management Product
    Table 129. Paratek Pharmaceuticals Inc Revenue in Acne Vulgaris Management Business (2019-2024) & (US$ Million)
    Table 130. Paratek Pharmaceuticals Inc Recent Development
    Table 131. Pfizer Inc Company Detail
    Table 132. Pfizer Inc Business Overview
    Table 133. Pfizer Inc Acne Vulgaris Management Product
    Table 134. Pfizer Inc Revenue in Acne Vulgaris Management Business (2019-2024) & (US$ Million)
    Table 135. Pfizer Inc Recent Development
    Table 136. Phosphagenics Ltd Company Detail
    Table 137. Phosphagenics Ltd Business Overview
    Table 138. Phosphagenics Ltd Acne Vulgaris Management Product
    Table 139. Phosphagenics Ltd Revenue in Acne Vulgaris Management Business (2019-2024) & (US$ Million)
    Table 140. Phosphagenics Ltd Recent Development
    Table 141. Research Programs/Design for This Report
    Table 142. Key Data Information from Secondary Sources
    Table 143. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Acne Vulgaris Management Market Size Comparison by Type (2024-2030) & (US$ Million)
    Figure 2. Global Acne Vulgaris Management Market Share by Type: 2023 VS 2030
    Figure 3. CB-0601 Features
    Figure 4. CJM-112 Features
    Figure 5. CLS-007 Features
    Figure 6. Dapsone Features
    Figure 7. DFD-10 Features
    Figure 8. DLX-2323 Features
    Figure 9. Others Features
    Figure 10. Global Acne Vulgaris Management Market Size Comparison by Application (2024-2030) & (US$ Million)
    Figure 11. Global Acne Vulgaris Management Market Share by Application: 2023 VS 2030
    Figure 12. Clinic Case Studies
    Figure 13. Hospital Case Studies
    Figure 14. Others Case Studies
    Figure 15. Acne Vulgaris Management Report Years Considered
    Figure 16. Global Acne Vulgaris Management Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 17. Global Acne Vulgaris Management Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 18. Global Acne Vulgaris Management Market Share by Region: 2023 VS 2030
    Figure 19. Global Acne Vulgaris Management Market Share by Players in 2023
    Figure 20. Global Top Acne Vulgaris Management Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Acne Vulgaris Management as of 2023)
    Figure 21. The Top 10 and 5 Players Market Share by Acne Vulgaris Management Revenue in 2023
    Figure 22. North America Acne Vulgaris Management Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 23. North America Acne Vulgaris Management Market Share by Country (2019-2030)
    Figure 24. United States Acne Vulgaris Management Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 25. Canada Acne Vulgaris Management Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 26. Europe Acne Vulgaris Management Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 27. Europe Acne Vulgaris Management Market Share by Country (2019-2030)
    Figure 28. Germany Acne Vulgaris Management Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 29. France Acne Vulgaris Management Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. U.K. Acne Vulgaris Management Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. Italy Acne Vulgaris Management Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. Russia Acne Vulgaris Management Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. Nordic Countries Acne Vulgaris Management Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. Asia-Pacific Acne Vulgaris Management Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. Asia-Pacific Acne Vulgaris Management Market Share by Region (2019-2030)
    Figure 36. China Acne Vulgaris Management Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 37. Japan Acne Vulgaris Management Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 38. South Korea Acne Vulgaris Management Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 39. Southeast Asia Acne Vulgaris Management Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 40. India Acne Vulgaris Management Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 41. Australia Acne Vulgaris Management Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 42. Latin America Acne Vulgaris Management Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. Latin America Acne Vulgaris Management Market Share by Country (2019-2030)
    Figure 44. Mexico Acne Vulgaris Management Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. Brazil Acne Vulgaris Management Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. Middle East & Africa Acne Vulgaris Management Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. Middle East & Africa Acne Vulgaris Management Market Share by Country (2019-2030)
    Figure 48. Turkey Acne Vulgaris Management Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 49. Saudi Arabia Acne Vulgaris Management Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 50. Common Pharma Inc Revenue Growth Rate in Acne Vulgaris Management Business (2019-2024)
    Figure 51. Cutanea Life Sciences Inc Revenue Growth Rate in Acne Vulgaris Management Business (2019-2024)
    Figure 52. Dermira Inc Revenue Growth Rate in Acne Vulgaris Management Business (2019-2024)
    Figure 53. ELORAC Inc Revenue Growth Rate in Acne Vulgaris Management Business (2019-2024)
    Figure 54. Ensol Biosciences Inc Revenue Growth Rate in Acne Vulgaris Management Business (2019-2024)
    Figure 55. Foamix Pharmaceuticals Ltd Revenue Growth Rate in Acne Vulgaris Management Business (2019-2024)
    Figure 56. Galderma SA Revenue Growth Rate in Acne Vulgaris Management Business (2019-2024)
    Figure 57. GlaxoSmithKline Plc Revenue Growth Rate in Acne Vulgaris Management Business (2019-2024)
    Figure 58. Helix BioMedix Inc Revenue Growth Rate in Acne Vulgaris Management Business (2019-2024)
    Figure 59. Hovione FarmaCiencia SA Revenue Growth Rate in Acne Vulgaris Management Business (2019-2024)
    Figure 60. Lee's Pharmaceutical Holdings Ltd Revenue Growth Rate in Acne Vulgaris Management Business (2019-2024)
    Figure 61. LEO Pharma A/S Revenue Growth Rate in Acne Vulgaris Management Business (2019-2024)
    Figure 62. Novabiotics Ltd Revenue Growth Rate in Acne Vulgaris Management Business (2019-2024)
    Figure 63. Novan Inc Revenue Growth Rate in Acne Vulgaris Management Business (2019-2024)
    Figure 64. Novartis AG Revenue Growth Rate in Acne Vulgaris Management Business (2019-2024)
    Figure 65. Paratek Pharmaceuticals Inc Revenue Growth Rate in Acne Vulgaris Management Business (2019-2024)
    Figure 66. Pfizer Inc Revenue Growth Rate in Acne Vulgaris Management Business (2019-2024)
    Figure 67. Phosphagenics Ltd Revenue Growth Rate in Acne Vulgaris Management Business (2019-2024)
    Figure 68. Bottom-up and Top-down Approaches for This Report
    Figure 69. Data Triangulation
    Figure 70. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS

Global Acne Vulgaris Treatment Market Research Report 2025
Global Oral Acne Medicine Market Research Report 2024
Global Acne Patches Market Research Report 2025
Global Acne Face Wash Market Research Report 2025
Global Facial Acne Lotion Market Research Report 2025
Global Acne Prone Skin Care Product Market Research Report 2025
Global Acne Pimple Patches Market Research Report 2025
Global Salicylic Acid for Acne Market Research Report 2025
Global Oral Acne Medications Market Research Report 2024
Global Acne Fighting Face Mask Market Research Report 2025
Moderate To Severe Acne Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Liquid Acne Topical Drug Market Research Report 2024
Acne Prescription Medication Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Toners for Acne Prone Market Research Report 2025
Topical Acne Treatment Medications Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Anti Acne Dermal Patch Market
Global Pimple Patches Market Research Report 2025
Baby Acne Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Consumer Acne Medicine Market Research Report 2024
Global Acne Removal Gel Market Research Report 2025

RELATED REPORTS

Global Sun Care Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-37N3924
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Facial Skincare Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35H8470
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Facial Moisturizer Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-25N8391
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Face Cleansing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-11Q1907
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions